Galmed Pharmaceuticals Ltd.
GLMD
$1.55
-$0.08-4.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.10M | -3.21M | -1.12M | -1.12M | -1.28M |
| Total Depreciation and Amortization | -- | 0.00 | 74.00K | 74.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.00K | 1.83M | 120.00K | 120.00K | 154.00K |
| Change in Net Operating Assets | -141.00K | -587.00K | -92.00K | -92.00K | -718.00K |
| Cash from Operations | -1.17M | -1.97M | -1.02M | -1.02M | -1.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -231.00K | -3.55M | 1.39M | 1.39M | 432.00K |
| Cash from Investing | -231.00K | -3.55M | 1.39M | 1.39M | 432.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.51M | 448.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.51M | 448.00K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.00K | -5.07M | 375.00K | 375.00K | -1.40M |